ADB-FUBHQUCA
Synthetic cannabinoid
Overview[edit | edit source]
ADB-FUBHQUCA is a synthetic cannabinoid that has been identified in various designer drug products. It is part of a class of compounds that are designed to mimic the effects of tetrahydrocannabinol (THC), the primary psychoactive component of cannabis. These substances are often referred to as "synthetic cannabinoids" and are commonly found in products marketed as "spice" or "K2".
Chemical Structure[edit | edit source]
ADB-FUBHQUCA is chemically classified as an indazole-based synthetic cannabinoid. Its structure includes a 1-(4-fluorobenzyl)-1H-indazole-3-carboxamide core, which is a common feature among many synthetic cannabinoids. The presence of the fluorobenzyl group is thought to contribute to its high affinity for the cannabinoid receptors.
Pharmacology[edit | edit source]
Synthetic cannabinoids like ADB-FUBHQUCA act as agonists at the CB1 and CB2 cannabinoid receptors in the central nervous system. These receptors are part of the endocannabinoid system, which plays a role in regulating mood, memory, appetite, and pain sensation. The activation of these receptors by synthetic cannabinoids can lead to effects similar to those of THC, including euphoria, altered perception, and relaxation. However, synthetic cannabinoids can also cause severe adverse effects, such as tachycardia, hypertension, hallucinations, and seizures.
Legal Status[edit | edit source]
The legal status of ADB-FUBHQUCA varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of accepted medical use. Regulatory agencies often place synthetic cannabinoids under temporary or permanent bans to prevent their distribution and use.
Health Risks[edit | edit source]
The use of synthetic cannabinoids like ADB-FUBHQUCA is associated with significant health risks. These compounds can be much more potent than natural THC, leading to a higher likelihood of overdose and severe side effects. Users may experience anxiety, paranoia, psychosis, and cardiovascular complications. Long-term use can lead to addiction and withdrawal symptoms.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
